George Huang

George Huang is a precocious and multi-faceted individual with successful track records in finance, healthcare, research and real estate. George started out in graduate school doing his thesis research in the lab of Chemistry Nobel Laureate Professor Peter Agre MD at the Johns Hopkins University. After graduating with his PhD in 2006, George became an Editor with Stansberry Research and wrote an investment research newsletter which had a loyal following among biotech-savvy Wall Street institutional clients. Not surprisingly, he was headhunted to be a Senior Analyst at Sabretooth Capital, a billion-dollar ‘Tiger Cub’-pedigree hedge fund in New York City. His other success in New York was as Senior Vice President of Business Development with Retrophin Inc. (RTRX – listed on NASD), a biotechnology company, where he evaluated acquisitions and helped bring the company public. In 2014, George left New York to co-found Bridge Tower, a real estate investment fund. In the same year, George joined the Entopsis core team as its CFO.